7 hasil untuk "Xavier Filella"
Menampilkan 1–7 · 2,37 detik · RSS
-
Artikel Jurnal
Assaig i assagistes a Catalunya: del marxisme a la postmodernitat
L’autor revisa l’evolució de l’assaig català des de finals dels anys seixanta, en el moment de màxim auge del marxisme a Catalunya, fins a l’adveniment de la postmodernitat. La contracultura, el nacionalisme i els nous moviments socials emmarquen aquesta evolució que, finalment, va tenir en el…
-
Artikel Jurnal
Standardization of prostate-specific antigen assays: Impact on reference intervals and clinical decision thresholds
Background Prostate-specific antigen (PSA) remains the most widely used biomarker for prostate cancer screening, diagnosis, and monitoring. However, despite decades of standardization efforts, significant inter-assay variability persists, with important consequences for clinical interpretation and…
-
Artikel Jurnal
Emergence of oligoclonal bands in patients with multiple myeloma in complete remission after induction chemotherapy: association with the use of novel agents
The emergence of oligoclonal bands is associated with a favorable outcome after autologous stem cell transplantation in multiple myeloma. The aim of this study was to determine the prevalence of immunoglobulin oligoclonality in 33 patients with multiple myeloma in complete remission achieved with…
-
Artikel Jurnal
Natural history and prognostic impact of oligoclonal humoral response in patients with multiple myeloma after autologous stem cell transplantation: long-term results from a single institution
The emergence of an oligoclonal humoral response, resulting in the appearance of a different serum M-protein to that observed at diagnosis is a well-recognized event after autologous stem cell transplantation in multiple myeloma in complete response, and it has been considered to be a benign…
-
Artikel Jurnal
Vertebral fracture risk in glucocorticoid-induced osteoporosis: the role of hypogonadism and corticosteroid boluses
Objective The aim of this study was to identify the risk factors associated with fragility fracture (FF) development in glucocorticoid (GC)-treated patients.Methods 127 patients (aged 62±18 years, 63% women) on GC-treatment (mean dose 14.5±14.1 mg/day and duration 47.7±69 months) were included. The…